Skip to Content

Join the 'Taxotere' group to help and get support from people like you.

Taxotere News

Cooling Mitts, Socks May Ease a Major Chemo Side Effect

Posted 18 Oct 2017 by

WEDNESDAY, Oct. 18, 2017 – Many cancer drugs can cause debilitating nerve damage as a side effect. But a small study suggests that simple cold wraps to the hands and feet might prevent it. The side effect, known as peripheral neuropathy, damages nerves in the limbs. This often leads to pain, numbness and tingling, and difficulty with balance and using the hands and fingers. There are treatments ...

Treatment Costs Can Be Another Blow to Cancer Patients

Posted 27 Jul 2017 by

THURSDAY, July 27, 2017 – The emotional and physical costs of cancer can be staggering. But the financial side of cancer is also a great burden, with many patients in the United States struggling to pay for treatment, new research reveals. "The current health law has greatly improved access to meaningful health coverage for cancer patients, survivors and all those with chronic diseases," Chris ...

Doctors' Group Offers Ideas for Easing Cancer Costs

Posted 19 Jul 2017 by

WEDNESDAY, July 19, 2017 – New cancer drugs routinely cost $100,000 a year or more, and older cancer drugs are rising in price, too. Now, the American Society of Clinical Oncology (ASCO) has some suggestions for easing patients' money woes. The proposals include allowing Medicare to negotiate drug prices, legalizing the importation of drugs, and adopting bundled, or group, payment programs. In ...

FDA Clears Expanded Use of Cooling Cap to Reduce Hair Loss During Chemotherapy

Posted 6 Jul 2017 by

July 3, 2017 – Today, the U.S. Food and Drug Administration cleared the expanded use of a cooling cap, DigniCap Cooling System, to reduce hair loss (alopecia) during chemotherapy. This is the first cooling cap cleared by the agency for use in cancer patients with solid tumors. “We are pleased to expand the use of this product for cancer patients with solid tumors to potentially minimize c ...

Publicly Funded Cancer Trials Gained Americans 3 Million More Years

Posted 6 Jun 2017 by

TUESDAY, June 6, 2017 – Public-funded trials have significantly extended the lives of people diagnosed with cancer, according to new research. SWOG, the clinical trials network funded by the U.S. National Cancer Institute (NCI), has involved more than 200,000 patient volunteers. These trials have led to approval of 14 new cancer drugs and more than 100 changes to cancer care standards. All told, ...

Half Report Severe Side Effects From Breast Cancer Therapy

Posted 24 Jan 2017 by

TUESDAY, Jan. 24, 2017 – About half of early stage breast cancer patients experience severe side effects from their treatment, a new study finds. "It's in patients' best interest to receive their treatments on time and on schedule, whenever possible, to give them the best possible outcome," said study author Dr. Steven Katz. He's professor of health management and policy at the University of ...

U.S. Pays Highest Prices for Cancer Meds: Study

Posted 6 Jun 2016 by

MONDAY, June 6, 2016 – The United States pays the highest prices in the world for generic and brand-name cancer drugs, a new study has found. However, as the world's wealthiest nation, the United States is better able to pay for those pricey drugs than poorer countries with somewhat lower medication prices, added study lead author Dr. Daniel Goldstein. People in China and India are much less ...

Keytruda May Help Fight Tough-to-Treat Lung Cancer

Posted 21 Dec 2015 by

SATURDAY, Dec. 19, 2015 – The immune therapy drug Keytruda (pembrolizumab) may extend the lives of people with advanced lung cancer, a new study finds. Keytruda is commonly used to treat other tumor types, and made headlines recently after it helped former President Jimmy Carter fight off brain cancer. In this study, researchers compared Keytruda to the chemotherapy drug docetaxel in more than ...

New Drug May Boost Survival a Bit for Some With Advanced Lung Cancer

Posted 28 Sep 2015 by

SUNDAY, Sept. 27, 2015 – A new study finds that the cancer drug nivolumab (Opdivo) extends the lives of some patients with advanced lung cancer for several months. In a head-to-head comparison, patients treated with nivolumab lived an average of 12.2 months, while patients treated with the chemotherapy drug docetaxel lived an average of 9.4 months, the researchers reported. "It looks like we ...

Immune-Based Drug Opdivo Shows Potential Against Another Form of Lung Cancer

Posted 1 Jun 2015 by

SUNDAY, May 31, 2015 – Another study finds that a new immune system-focused drug, called nivolumab, may help treat a common form of lung cancer. On Saturday, a study presented at the annual meeting of the American Society of Clinical Oncology in Chicago found that nivolumab cut patients' risk of death from non-small cell lung cancer (NSCLC) – the most common form of the disease – by 27 ...

Immune-Based Drug Shows Promise Against Advanced Lung Cancer

Posted 29 May 2015 by

FRIDAY, May 29, 2015 – A new drug appears to harness a person's immune system to fight the most common form of lung cancer, according to new clinical trial findings. The drug, nivolumab, reduced patients' risk of death from non-small cell lung cancer by 27 percent compared with patients who received docetaxel, a commonly used chemotherapy medication, researchers said. The study results are ...

Early Chemo May Boost Survival in Advanced Prostate Cancer

Posted 14 May 2015 by

THURSDAY, May 14, 2015 – Starting the chemotherapy drug docetaxel at the same time as hormone therapy can improve survival for men with newly diagnosed, advanced prostate cancer, British researchers say. Currently, chemotherapy is generally given after hormone therapy stops working. But the new study found that when the two therapies were paired at the start of treatment, patients lived an ...

Medicines Are Biggest Culprit in Fatal Allergic Reactions: Study

Posted 10 Oct 2014 by

THURSDAY, Oct. 9, 2014 – Although food allergies have garnered a lot of attention lately, a new study reports that medications are actually the biggest cause of sudden deaths related to allergy. Over a little more than a decade, nearly 60 percent of the allergy-related deaths were caused by medications, while less than 7 percent were caused by food allergies, the study found. "Medications can be ...

New Guidelines for Treating Advanced Prostate Cancer

Posted 8 Sep 2014 by

MONDAY, Sept. 8, 2014 – Men newly diagnosed with prostate cancer often turn first to testosterone-depleting therapies, since male hormones help prostate tumors grow. But, those therapies almost always fail over time as the tumor develops resistance, according to oncologists. Now, experts are issuing updated guidelines to help patients in this situation decide what to do next. The guidelines, ...

FDA Medwatch Alert: Docetaxel: Drug Safety Communication - May Cause Symptoms of Alcohol Intoxication

Posted 24 Jun 2014 by

ISSUE: FDA is warning that the intravenous chemotherapy drug docetaxel contains ethanol, also known as alcohol, which may cause patients to experience intoxication or feel drunk during and after treatment. FDA is revising the labels of all docetaxel drug products to warn about this risk.  BACKGROUND: Docetaxel is a prescription chemotherapy drug used to treat different kinds of cancer, including ...

Page 1 2 Next

Ask a Question

Further Information

Related Condition Support Groups

Breast Cancer, Breast Cancer, Metastatic, Non-Small Cell Lung Cancer, Head and Neck Cancer, Gastric Cancer, Prostate Cancer, Solid Tumors

Taxotere Patient Information at